Progressive Multifocal Leukoencephalopathy Following Heightened Immunosuppression After Lung Transplant

Journal of Heart and Lung Transplantation

Volumn 28, Issue 4, 2009, Pages 395-398

  Waggoner, Jesse ^a   Martinu, Tereza ^a   Palmer, Scott M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B; AZATHIOPRINE; CD4 ANTIGEN; CIDOFOVIR; COTRIMOXAZOLE; GANCICLOVIR; METHYLPREDNISOLONE; MIRTAZAPINE; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FIBROSIS; LUNG INFECTION; LUNG TRANSPLANTATION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RECIPIENT; RESPIRATORY FAILURE; SEPSIS; SINGLE DRUG DOSE; SYMPTOMATOLOGY;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTILYMPHOCYTE SERUM; BRAIN; CYTOSINE; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LUNG TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; PHOSPHONIC ACIDS; PULMONARY FIBROSIS; TREATMENT OUTCOME;

EID: 62949120130     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.12.010     Document Type: Article

References (22)

1. Aström K.E., Mancall E.L., and Richardson Jr. E.P. Progressive multifocal leukoencephalopathy: a hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkin's disease. Brain 81 (1958) 93-111
2. Demeter L.M. JC, BK, and other polyomaviruses; progressive multifocal leukoencephalopathy. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. 6th ed. (2005), Elsevier, Philadelphia 1856-1863
3. Padgett B.L., ZuRhein G.M., Walker D.L., et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 297 (1971) 1257-1260
4. White III F.A., Ishaq M., Stoner G.L., et al. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 66 (1992) 5726-5734
5. Shitrit D., Nitrit L., Bar-Gil-Shitrit A., et al. Progressive multifocal leukoencephalopathy in transplant recipients. Transplant Int 17 (2005) 658-665
6. Ouwens J.P., Haaxma-Reiche H., Verschuuren E.A., et al. Visual symptoms after lung transplantation: a case of progressive multifocal leukoencephalopathy. Transplant Infect Dis 2 (2000) 29-32
7. Shitrit D., Nirit L., Shiran S.I., et al. Progressive multifocal leukoencephalopathy in a lung transplant recipient. J Heart Lung Transplant 22 (2003) 946-950
8. Goodin D.S., Cohen B.A., O'Connor P., et al. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review). Neurology 71 (2008) 766-773
9. Dias B., Shoemaker L., Recto M., et al. Alemtuzumab (Campath-1H) induction in a pediatric heart transplant: successful outcome and rationale for its use. J Heart Lung Transplant 27 (2008) 242-244
10. Reams D.B., Davis D.R., Curl J., et al. Treatment of refractory acute rejection in a lung transplant recipient with Campath 1H. Transplantation 71 (2002) 903-904
11. Woodside K.J., and Lick S.D. Alemtuzumab (Campath 1H) as successful salvage therapy for recurrent steroid-resistant heart transplant rejection. J Heart Lung Transplant 26 (2007) 750-752
12. Peleg A.Y., Husain S., Kwak E.J., et al. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis 44 (2007) 204-212
13. Louis S., Audrain M., Catarovich D., et al. Long-term cell monitoring of kidney recipients after an antilymphocyte globulin induction with and without steroids. Transplantation 83 (2007) 712-721
14. Ally R., Schurmann D., Kreisel W., et al. A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin Infect Dis 33 (2001) 1447-1454
15. Hinchey J., Chaves C., Appignani B., et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334 (1996) 494-500
16. Fong I.W., Britton C.B., Luinstra K.E., et al. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid in patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 33 (1995) 484-486
17. Marra C.M., Rajicic N., Barker D.E., et al. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16 (2002) 1791-1797
18. Clinical Pharmacology. http://classic.clinicalpharmacology-ip.com (accessed 11 March 11, 2008)
19. Verma S., Cikurel K., Koralnik I.J., et al. Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis 196 (2007) 709-711
20. Uppenkamp M., Engert A., Diehl V., et al. Monoclonal antibody therapy with CAMPATH-1H in patients with relapse high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study. Ann Hematol 81 (2002) 26-32
21. Martin S.I., Marty F.M., Fiumara K., et al. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. CID 43 (2006) 16-24
22. Verbeeck J., Van Assche G., Ryding J., et al. JC viral loads in Crohn's disease patients treated with immunosuppression: can we screen for elevated risk of PML?. Gut 57 (2008) 1393-1397